Hugo Gagnon, Ph.D.

Hugo became the Chief Scientific Officer when Allumiqs was created in early 2022. Previously, he served as the CEO and co-founder of PhenoSwitch Bioscience, which was acquired by Proteoform Scientific to create Allumiqs.

During his Ph.D Hugo used mass spectrometry through different collaborations and core facility services to answer biological questions. He quickly learned that access to mass spectrometry was far from being simple and necessitates a considerable resource investment to obtain desirable results. Thus, PhenoSwitch Bioscience was founded, with a team of expert scientists, to address this specific need. Hugo studied at Université de Sherbrooke, where he earned a B.Sc. in biochemistry, M.Sc. in Pharmacology, and a Ph.D. in biochemistry.

Hugo has been the driving force behind the innovative LC-MS/MS services offerings and high-quality reputation the company has developed within the biotech, omics, and mass spec industries.